Literature DB >> 3674090

Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections.

J Bernardini1, B Piraino, M Sorkin.   

Abstract

The outcomes of all continuous ambulatory peritoneal dialysis-related infections due to Pseudomonas aeruginosa (n = 33) were analyzed and compared with the outcomes of infections due to all other microorganisms (n = 663) over a seven-year period. There were 16 catheter infections (exit site or tunnel infection or both), seven episodes of peritonitis, and 10 episodes of catheter infections associated with peritonitis due to P. aeruginosa. Catheters were removed in 58 percent (19 of 33) of the infections due to P. aeruginosa, but in only 16 percent (104 of 663) of the infections due to other organisms (p less than 0.01). All P. aeruginosa catheter infections associated with P. aeruginosa peritonitis resulted in catheter loss. P. aeruginosa catheter infections not associated with peritonitis also often did not resolve with antibiotic therapy (nine of 16 or 56 percent of catheters removed compared with 42 of 317 or 13 percent of catheters removed for other organisms, p less than 0.01). However, P. aeruginosa peritonitis episodes that were not associated with a catheter infection were no more likely to result in catheter loss than were peritonitis episodes due to other organisms (one of seven compared with 37 of 256, 14 percent for both). It is concluded that catheter infections due to P. aeruginosa with or without associated peritonitis usually require catheter removal. Conversely, P. aeruginosa peritonitis without a catheter infection often does not require catheter removal.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674090     DOI: 10.1016/0002-9343(87)90638-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Modification of dienes mutual inhibition test for epidemiological characterization of Pseudomonas aeruginosa isolates.

Authors:  Erik L Munson; Michael A Pfaller; Gary V Doern
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 2.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

3.  Ultrasound evaluation of peritoneal catheter tunnel in catheter related infections in CAPD.

Authors:  O Ibrahim Karahan; Hulya Taskapan; Ali Yikilmaz; Oktay Oymak; Cengiz Utas
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

4.  Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.

Authors:  Lily Mushahar; Lim Wei Mei; Wan Shaariah Yusuf; Sudhaharan Sivathasan; Norilah Kamaruddin; Nor Juliana Mohd Idzham
Journal:  Perit Dial Int       Date:  2015-09-15       Impact factor: 1.756

5.  In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

Authors:  D C Halstead; J Guzzo; J A Giardina; A E Geshan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

6.  Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases.

Authors:  Brian Siva; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Johan B Rosman; Kathryn J Wiggins; Kym M Bannister; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

Review 7.  Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  A von Graevenitz; D Amsterdam
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

8.  Successful antibiotic treatment of Pseudomonas stutzeri-induced peritonitis without peritoneal dialysis catheter removal in continuous ambulatory peritoneal dialysis.

Authors:  Sung Wook Park; Ji Hyeon Back; Seoung Woo Lee; Joon Ho Song; Chun Ho Shin; Gyung Eun Kim; Moon-Jae Kim
Journal:  Kidney Res Clin Pract       Date:  2013-05-22

9.  Compatibility of aztreonam in four commercial peritoneal dialysis fluids.

Authors:  Selma Tobudic; Isabella Prager; Manuel Kussmann; Markus Obermüller; Martin Ursli; Markus Zeitlinger; Martin Wiesholzer; Heinz Burgmann; Wolfgang Poeppl; Gottfried Reznicek
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

Review 10.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.